US Pharma & Biotech Oncology - PPC Market Share Analysis February 2026

Leveraging Adthena’s Whole Market View, this analysis explores recent trends in Google Ads for the US Oncology category from the last month. Our Data Analyst, Ask Arlo provides commentary on key findings.

Oncology – US

Google AI Overview visibility for Pharma & Biotech Oncology US

See how often AIOs appear and how search intent is distributed across buying signals.

AIO Frequency

How often a Google AI overview appears on search terms relevant to this category.

Frequency Percentage
Frequency 70.0510984962
29.9489015038
70%

Complex Query Frequency

A complex query is a longer, more detailed search that often contains multiple keywords, specific conditions, or multi-part questions.

Frequency Percentage
Frequency 40
60
40%

Search Intent Distribution

Breakdown of search queries by their underlying goal.

Intent Distribution
Investigational 3%
Transactional 2%
Navigational 0%
Seasonal 0%
Local 0%
Problem Solving 25%

Copyright © Adthena. All rights reserved.

Market Exposure

Share of Clicks for top 10 US Pharma & Biotech Oncology brands

Here are the Top 10 competitors in the industry by Share of Clicks for the last month.

Share of Clicks - Last month
Share of Clicks - Last month
Domain Share of clicks
themmrf.org 8.79
breyanzi.com 5.18
mayoclinic.org 4.65
lymphoma.org 3.71
lilly.com 2.95
imbcr.org 2.38
mdanderson.org 2.23
cancer.org 2.23
thermofisher.com 2.17
healthline.com 1.96
others 63.75
  • themmrf.org - 8.79%
  • breyanzi.com - 5.18%
  • mayoclinic.org - 4.65%
  • lymphoma.org - 3.71%
  • lilly.com - 2.95%
  • imbcr.org - 2.38%
  • mdanderson.org - 2.23%
  • cancer.org - 2.23%
  • thermofisher.com - 2.17%
  • healthline.com - 1.96%
  • others - 63.75%

Copyright © Adthena. All rights reserved.

In the oncology PPC landscape, ‘others’ dominate with 63.75% click share, while themmrf.org leads specific domains at 8.79%, followed by breyanzi.com at 5.18%.

Market Exposure

Share of Spend for the top 10 US Pharma & Biotech Oncology brands

Curious about your market position? Here you can see the Top 10 competitors in the industry by Share of Spend for the last month. 

Share of Spend - Last Month
Share of Spend - Last Month
Date themmrf.org lymphoma.org breyanzi.com mayoclinic.org imbcr.org nubeqa-us.com lilly.com keytruda.com kisqali.com kisqali-hcp.com
2026/02/01 9.49% 1.97% 3.12% 2.52% 4.35% 2.25% 1.6% 2.01% 7.13% 3.27%
2026/02/02 7.32% 3.79% 3.77% 3.08% 4.16% 1.3% 2.82% 2.11% 8.52% 4.24%
2026/02/03 5.36% 2.17% 4.47% 1.86% 2.38% 2.41% 2.66% 1.42% 4.73% 2.59%
2026/02/04 7.44% 2.67% 4.27% 4.04% 1.38% 1.58% 3.11% 1.88% 6.25% 3.54%
2026/02/05 7.37% 3.69% 3.52% 4.49% 2.1% 2.29% 1.97% 2.29% 5.11% 2.82%
2026/02/06 5.01% 3.97% 5.51% 3.32% 1.32% 2.32% 3.36% 2.32% 6.65% 3.05%
2026/02/07 4.26% 3.29% 4.42% 2.34% 3.32% 2.56% 3.52% 2.58% 4.29% 1.71%
2026/02/08 3.67% 1.73% 3.71% 3.37% 2.18% 2.62% 2.37% 2.78% 6.96% 3.78%
2026/02/09 5.16% 2.52% 3.92% 3.77% 3.48% 1.54% 3.54% 1.37% 6.11% 3.03%
2026/02/10 4.71% 3.76% 4.77% 3.49% 2.25% 1.81% 2.85% 2.42% 7.7% 3.99%
2026/02/11 6.47% 2.87% 4.27% 3.36% 1.11% 1.77% 3.73% 1.94% 5.71% 2.5%
2026/02/12 7.27% 3.64% 3.47% 4.43% 2.07% 2.25% 1.94% 2.26% 5.04% 2.78%
2026/02/13 4.97% 3.94% 5.46% 3.29% 1.31% 2.3% 3.35% 2.3% 6.6% 3.02%
2026/02/14 4.24% 3.28% 4.4% 2.33% 3.3% 2.54% 3.51% 2.56% 4.27% 1.7%
2026/02/15 3.65% 1.72% 3.69% 3.35% 2.17% 2.6% 2.35% 2.77% 6.92% 3.75%
2026/02/16 5.11% 2.49% 3.87% 3.73% 3.45% 1.52% 3.5% 1.35% 6.05% 3%
2026/02/17 8.43% 1.02% 2.74% 2.54% 1.37% 0.95% 3.42% 2.82% 8.34% 6.16%
2026/02/18 7.17% 4.69% 4.93% 4.04% 1.09% 2.49% 3.58% 1.53% 3.42% 2.55%
2026/02/19 12.5% 3.25% 5.04% 5.91% 1.38% 2.57% 3.9% 1.93% 2.21% 1.76%
2026/02/20 14.25% 4.67% 4.56% 2.62% 1.09% 3.58% 2.82% 1.72% 1.93% 1.55%
2026/02/21 13.76% 5.14% 5.01% 3.53% 2.99% 2.78% 2.02% 0.9% 2.31% 0.83%
2026/02/22 8.51% 4.31% 5.62% 3.83% 2.4% 2.37% 2.6% 1.05% 4.19% 1.99%
2026/02/23 12.32% 4.93% 5.13% 4.05% 1.51% 2.53% 5.54% 0.77% 1.53% 0.87%
2026/02/24 8.82% 4.86% 5.65% 3.67% 1.44% 2.02% 4.49% 1.04% 1.9% 1.11%
2026/02/25 13.06% 3.8% 5.48% 3.42% 1.56% 2.28% 3.52% 1.19% 1.47% 0.57%
2026/02/26 14.2% 5.42% 5.07% 3.31% 1.72% 2.51% 2.53% 1.49% 1.18% 0.86%
2026/02/27 10.55% 5.7% 7.1% 4.27% 0.46% 3.43% 3.21% 2.61% 0.94% 1.23%
2026/02/28 12.38% 5.72% 4.8% 4.38% 3.98% 3.36% 2.98% 1.91% 1.55% 0.94%
  • themmrf.org
  • lymphoma.org
  • breyanzi.com
  • mayoclinic.org
  • imbcr.org
  • nubeqa-us.com
  • lilly.com
  • keytruda.com
  • kisqali.com
  • kisqali-hcp.com

Copyright © Adthena. All rights reserved.

In February 2026, themmrf.org led with a significant surge mid-month, peaking at 14.25. Lymphoma.org and breyanzi.com maintained steady growth, while kisqali.com saw a decline. The month concluded with themmrf.org dominating.

Market Exposure

Competitor Count for US Pharma & Biotech Oncology

Ever wondered how many competitors you’re up against in your industry? Well look no further, here we can see the number of advertisers bidding over the last month. 

Competitor Count - Last month
Competitor Count - Last month
Date Competitor Count
2026/02/01 431
2026/02/02 456
2026/02/03 425
2026/02/04 427
2026/02/05 439
2026/02/06 419
2026/02/07 428
2026/02/08 438
2026/02/09 428
2026/02/10 437
2026/02/11 445
2026/02/12 439
2026/02/13 419
2026/02/14 428
2026/02/15 438
2026/02/16 428
2026/02/17 427
2026/02/18 442
2026/02/19 447
2026/02/20 427
2026/02/21 422
2026/02/22 433
2026/02/23 438
2026/02/24 443
2026/02/25 427
2026/02/26 412
2026/02/27 410
2026/02/28 398

Copyright © Adthena. All rights reserved.

February began with 431 advertisers, peaking at 456 on the 2nd. A steady decline followed, ending the month at 398.

Campaign Efficiency

Market Loss & Market Gains for US Pharma & Biotech Oncology

Here we’re looking at the Top 10 biggest industry movers by market share gains and losses for the last 30 days.

Market Loss & Market Gains - Last month
Market Loss & Market Gains - Last month
Name Market Trend
themmrf.org 4.51%
thermofisher.com 1.29%
lymphoma.org 0.84%
xpovio.com 0.47%
envita.com 0.46%
imbcr.org -0.72%
kisqali.com -0.82%
datrowayhcp.com -0.9%
lunsumio.com -1.29%
healthline.com -1.49%

Copyright © Adthena. All rights reserved.

Themmrf.org surged with a 4.51% click share increase, while healthline.com dropped by 1.49%. Thermofisher.com also rose by 1.29%, contrasting lunsumio.com’s 1.29% decline.

Campaign Efficiency

US Pharma & Biotech Oncology Share of Impressions

Take a look at the Top 10 competitors in the industry by Share of Impressions over the last month.

Date themmrf.org breyanzi.com imbcr.org lymphoma.org mayoclinic.org orserdu.com lilly.com mdanderson.org thermofisher.com healthline.com
2026/02/01 6.47% 3.4% 6.76% 1.72% 2.18% 1.69% 1.73% 4.62% 0.82% 5.46%
2026/02/02 5.14% 4.74% 6.08% 3.26% 3.19% 2.05% 2.54% 1.93% 0.77% 0.09%
2026/02/03 3.28% 5.82% 2.75% 1.86% 1.7% 2.76% 3.02% 1.22% 2.75% 3.03%
2026/02/04 5.31% 4.81% 2.22% 2.44% 4.36% 3.27% 3.17% 0.95% 2.57% 4.24%
2026/02/05 5.17% 4.55% 2.6% 3.37% 3.67% 3.12% 2.49% 1.51% 1.68% 3.61%
2026/02/06 3.48% 7.25% 1.84% 3.6% 2.77% 3.27% 3.81% 1.84% 1.59% 2.93%
2026/02/07 3.52% 5.8% 4.3% 2.62% 2.22% 2.73% 3.44% 2.14% 0.9% 3.03%
2026/02/08 2.89% 4.62% 2.78% 1.62% 3.15% 2.6% 2.43% 3.74% 3.46% 3.22%
2026/02/09 4.56% 4.59% 4.33% 2.27% 3.85% 2.79% 4.46% 1.32% 2.55% 3.1%
2026/02/10 3.88% 6.4% 2.93% 3.24% 3.69% 2.94% 3.82% 1.06% 2.53% 3.62%
2026/02/11 5.23% 5.58% 1.6% 2.86% 3.7% 3.83% 4.61% 0.66% 3.58% 3.88%
2026/02/12 5.17% 4.55% 2.6% 3.37% 3.67% 3.12% 2.49% 1.51% 1.68% 3.61%
2026/02/13 3.48% 7.25% 1.84% 3.6% 2.77% 3.27% 3.81% 1.84% 1.59% 2.93%
2026/02/14 3.52% 5.8% 4.3% 2.62% 2.22% 2.73% 3.44% 2.14% 0.9% 3.03%
2026/02/15 2.89% 4.62% 2.78% 1.62% 3.15% 2.6% 2.43% 3.74% 3.46% 3.22%
2026/02/16 4.56% 4.59% 4.33% 2.27% 3.85% 2.79% 4.46% 1.32% 2.55% 3.1%
2026/02/17 7.65% 3.52% 2.48% 1.08% 2.38% 0.49% 3.37% 2.08% 3.14% 0.48%
2026/02/18 5.5% 5.94% 1.73% 3.85% 3.17% 2.35% 4.34% 1.94% 4.6% 2.28%
2026/02/19 8.87% 6.08% 2.12% 3.03% 4.72% 2.14% 4.24% 1.52% 3.54% 0.94%
2026/02/20 10.12% 5.28% 1.86% 4.31% 1.93% 1.98% 3.82% 1.21% 3.37% 1.51%
2026/02/21 10.29% 5.97% 4.02% 4.78% 3.03% 2.08% 2.26% 3.17% 3.78% 1.49%
2026/02/22 6.46% 7.21% 3.31% 3.73% 3.21% 2.49% 2.45% 5.4% 2.84% 1.36%
2026/02/23 8.38% 5.54% 1.94% 3.87% 3.72% 3.65% 5.46% 1.18% 3.83% 1.8%
2026/02/24 6.56% 6.65% 1.84% 4.23% 2.76% 3.07% 4.57% 2.65% 5.23% 1.27%
2026/02/25 9.09% 6.3% 1.91% 3.72% 2.87% 2.81% 3.33% 1.09% 4.67% 0.89%
2026/02/26 10.09% 6% 2.38% 4.19% 2.48% 2.65% 2.71% 0.61% 4.68% 0.55%
2026/02/27 8.57% 8.29% 0.61% 4.24% 4.22% 3.37% 3.02% 0.65% 1.51% 0.43%
2026/02/28 8.59% 5.76% 5.22% 4.73% 3.87% 3.73% 2.79% 2.55% 1.86% 0.34%
  • themmrf.org
  • breyanzi.com
  • imbcr.org
  • lymphoma.org
  • mayoclinic.org
  • orserdu.com
  • lilly.com
  • mdanderson.org
  • thermofisher.com
  • healthline.com

Copyright © Adthena. All rights reserved.

In February 2026, themmrf.org’s impression share surged mid-month, peaking at 10.29% on the 21st. Breyanzi.com maintained steady growth, while imbcr.org fluctuated, ending with a notable 5.22%. Lymphoma.org and mayoclinic.org showed consistent performance, with lymphoma.org peaking at 4.78% on the 21st. Orserdu.com and lilly.com had moderate fluctuations, while mdanderson.org and thermofisher.com experienced varied trends. Healthline.com started strong but declined, finishing at 0.34%.

Campaign Efficiency

Google Text Ad Copy Insights & Creative Trends for US Pharma & Biotech Oncology

Ever wondered how your rivals’ ads are doing? Here we can see the top-performing ads in the industry over the last month.

Google Text Ad Copy Insights & Creative Trends for US Pharma & Biotech Oncology - Last month
  1. 1
    Multiple Myeloma Prognosis: Staging, Survival Rates https://www.healthline.com

    Multiple myeloma is a cancer in which abnormal cells reproduce in your bone marrow.

  2. 2
    Understanding HER2+ eBC - Early Stage Breast Cancer Info https://www.her2empowered.com › patient › resource

    Patients, Familiarize Yourself With A Few Treatment Options For HER2+ Early Breast Cancer.

  3. 3
    What is Myeloma? - What Are Symptoms Of Myeloma? https://www.imbcr.org › myeloma

    Symptoms may include bone damage, high calcium levels, anemia, kidney...

  4. 4
    ER+/HER2- ESR1m mBC Therapy - FDA Approved Treatment Prescription treatment website

    Visit the Site to Learn About ESR1 Mutations in mBC & View an Available Treatment Option.

  5. 5
    What is Triple Negative BC? - Triple Negative Breast Cancer https://www.tnbcfoundation.org

    Access TNBC resources for patients & caregivers to assist before, during & after treatment

Copyright © Adthena. All rights reserved.

In the competitive landscape of oncology PPC ads, Healthline and IMBCR focus on educating about myeloma, while HER2 Empowered and Orserdu highlight specific breast cancer treatments. TNBC Foundation offers comprehensive support resources, emphasizing patient and caregiver empowerment.

Frequently Asked Questions

Customer Success Stories

Get the full picture

See this data specific to your brand performance

The data on this page is just a sample of the billions of data points we hold at Adthena. The insights generated by Ask Arlo, leverage real-time GenAI to answer questions about your search data.

Our search consultants can introduce you to Whole Market View data that is specific to your organization, based on the size of the relevant search term and competitor universe, and the locations that you need monitoring.